Uipath, INC Form 4 insider transactions
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines executed the sale of 90,000 shares of Class A Common Stock over two days in June 2025, totaling approximately $1.16 million, as part of a pre-established Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $593,491 under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.08 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $589,779, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines has sold 45,000 shares of Class A Common Stock for approximately $592,492 under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 4, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 3, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.31 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $13.176 per share on May 14, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $13.1224, according to a Form 4 filing.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.8332, pursuant to a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.5076, according to a Form 4 filing.
NYSE
PATH
Uipath, INCUiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.1619, according to a Form 4 filing.
NYSE
PATH
Uipath, INCUiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.0284, according to a Form 4 filing with the SEC.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 14,900 shares of Class A Common Stock at an average price of $12.0077 per share on May 6, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 24,979 shares of Class A Common Stock at an average price of $12.0279 on May 5, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.0152, according to a Form 4 filing with the SEC.
NYSE
PATH
Uipath, INCAshim Gupta, COO & CFO of UiPath, sold 99,300 shares of Class A Common Stock on May 1, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's CEO, Daniel Dines, executed a sale of 45,000 shares of Class A Common Stock at an average price of $12.0058, as part of a pre-arranged trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 12,500 shares of Class A Common Stock at an average price of $10.1858, as part of a pre-arranged trading plan.
NYSE
PATH
Uipath, INCBrad Brubaker, GC & Chief Legal Officer of UiPath, reports disposing of shares to cover tax obligations arising from vested restricted stock units.
NYSE
PATH
Uipath, INCAshim Gupta, COO & CFO of UiPath, reports the disposal of shares to cover tax obligations upon the vesting of restricted stock units.
NYSE
PATH
Uipath, INCHitesh Ramani, Chief Accounting Officer of UiPath, disposed of 22,595 shares of Class A Common Stock on April 1, 2025, to cover tax obligations arising from the vesting of restricted stock units.
NYSE
PATH
Uipath, INCHitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition of 93,065 shares of Class A Common Stock through Restricted Stock Units (RSUs).
NYSE
PATH
Uipath, INCAshim Gupta, COO & CFO of UiPath, reports acquiring 288,321 shares of Class A Common Stock through Restricted Stock Units (RSUs) on March 14, 2025.
NYSE
PATH
Uipath, INCBrad Brubaker, GC & Chief Legal Officer of UiPath, reports the acquisition of 145,985 Restricted Stock Units (RSUs) on March 14, 2025.
NYSE
PATH
Uipath, INCForm 4: UiPath CEO Daniel Dines Converts 5 Million Class B Shares to Class A Under 10b5-1 Trading Plan
UiPath's CEO, Daniel Dines, converted 5 million Class B shares to Class A shares on March 13, 2025, under a pre-arranged trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 12,500 shares of Class A Common Stock at an average price of $12.6759, according to a Form 4 filing.
NYSE
PATH
Uipath, INCHitesh Ramani, Chief Accounting Officer of UiPath, reports the disposal and acquisition of Class A Common Stock on January 2nd and 3rd, 2025.
NYSE
PATH
Uipath, INCAshim Gupta, COO & CFO of UiPath, reports the disposition and acquisition of Class A Common Stock on January 2nd and 3rd, 2025.